Antioxidant and Gene Regulation Laboratory, Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA, USA.
Int J Obes (Lond). 2013 Nov;37(11):1490-8. doi: 10.1038/ijo.2013.9. Epub 2013 Feb 5.
Obesity is associated with an increase in various pro-inflammatory and anti-inflammatory cytokines, but the interplay of these cytokines is incompletely understood. We conducted experiments to test a broader hypothesis that a dynamic interplay of pro-inflammatory and anti-inflammatory cytokines controls lipid storage in adipocytes.
Three experiments were designed to test the overall hypothesis that proinflammatory cytokine (for example, tumor necrosis factor-α (TNF-α) inhibits anti-inflammatory cytokine (for example, adiponectin) activity in an attempt to limit excess lipid accumulation in adipocytes.
Experiment one showed that in pro-inflammatory animal models (ap2-P65, ob/ob and high-fat diet-induced obese mice), the increase in TNF-α expression was associated with a decrease in adiponectin expression. Experiment two showed that in 3T3-L1 adipocytes, TNF-α significantly reduced lipid accumulation and glucose uptake induced by adiponectin, and increased lipolysis. Experiment three showed that in 3T3-L1 adipocytes, TNF-α reduced mRNA and protein expression of adiponectin. Adiponectin gene transcription and mRNA stability were both reduced by TNF-α. The expression of peroxisome proliferator-activated receptor gamma, an activator of adiponectin gene promoter, was reduced by TNF-α. The inhibitory activity of TNF-α was blocked by the chemical inhibitors of NF-κB and super suppressor IκBα.
TNF-α opposes the action of adiponectin in the regulation of lipid metabolism, and inhibits adiponectin expression at transcriptional and post-transcriptional levels. The results suggest that pro-inflammatory cytokine inhibit anti-inflammatory cytokine in adipocytes to reduce lipid storage. This suggests a potential role of anti-inflammatory cytokines in the control of adipose tissue expansion.
肥胖与多种促炎和抗炎细胞因子的增加有关,但这些细胞因子的相互作用尚不完全清楚。我们进行了实验来检验一个更广泛的假说,即促炎和抗炎细胞因子的动态相互作用控制脂肪细胞中的脂质储存。
设计了三个实验来检验总体假说,即促炎细胞因子(例如肿瘤坏死因子-α(TNF-α))抑制抗炎细胞因子(例如脂联素)的活性,试图限制脂肪细胞中过多的脂质积累。
实验一表明,在促炎动物模型(ap2-P65、ob/ob 和高脂肪饮食诱导肥胖小鼠)中,TNF-α表达的增加与脂联素表达的减少相关。实验二表明,在 3T3-L1 脂肪细胞中,TNF-α显著降低了脂联素诱导的脂质积累和葡萄糖摄取,并增加了脂肪分解。实验三表明,在 3T3-L1 脂肪细胞中,TNF-α降低了脂联素的 mRNA 和蛋白表达。TNF-α降低了脂联素基因转录和 mRNA 稳定性。过氧化物酶体增殖物激活受体 γ(脂联素基因启动子的激活剂)的表达被 TNF-α降低。TNF-α的抑制活性被 NF-κB 的化学抑制剂和超级抑制 IκBα 阻断。
TNF-α拮抗脂联素在调节脂质代谢中的作用,并在转录和转录后水平抑制脂联素的表达。结果表明,促炎细胞因子抑制脂肪细胞中的抗炎细胞因子以减少脂质储存。这表明抗炎细胞因子在控制脂肪组织扩张中可能发挥作用。